This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Garth W. Englund, MD
Valley View Hospital Denver

JAMA. 1969;210(12):2282.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:—

Acetazolamide (Diamox), a sulfonamide and a potent carbonic anhydrase inhibitor, is used in the control of fluid secretion and in the promotion of diuresis in cases of fluid retention. Adverse reactions to sulfonamides are well known, however, a brief review of the literature revealed only two previously reported cases of bone marrow depression due to acetazolamide, one with recovery,¹ and one fatal.² To these is added one of severe, fatal bone marrow depression with leukopenia, thrombocytopenia, and anemia after 3 1/2 months of treatment for glaucoma with 500 mg twice daily.

Report of a Case:—

A 66-year-old man was hospitalized because of severe pharyngitis, stomatitis, and cheilitis which had an onset approximately five days prior to hospitalization and had not responded to treatment with lincomycin and penicillin. The patient had been well prior to this except for recent onset of weakness, fatigue, mild dyspnea, and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?